In vitro and in vivo evaluation of US-NCI compounds in human tumor xenografts
Authors:
- Dietmar P. BergerDBDietmar P. Berger
- Bernd R. WinterhalterBWBernd R. Winterhalter
- Jacqueline PlowmanJPJacqueline Plowman
- 1 September 1990
- journal article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 17 (2-3) , 109-117
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Schedule dependence, activity against natural metastases, and cross-resistance of pyrazine diazohydroxide (sodium salt, NSC 361456) in preclinical models in vivoCancer Chemotherapy and Pharmacology, 1990
- 4-Ipomeanol: A Novel Investigational New Drug for Lung CancerJNCI: Journal of the National Cancer Institute, 1989
- In vitro cytotoxicity of pyrazine-2-diazohydroxide: specificity for hypoxic cells and effects of microsomal coincubationInvestigational New Drugs, 1988
- The New NCI Screen and Its Implications for Clinical Evaluation1980
- Primary Bioassay of Human Tumor Stem CellsScience, 1977